GLP-1 receptor agonists and diabetic retinopathy: A meta-analysis of randomized clinical trials.
Kapoor I, Sarvepalli SM, D'Alessio D, Grewal DS, Hadziahmetovic M.
Surv Ophthalmol. 2023 Nov-Dec;68(6):1071-1083. doi: 10.1016/j.survophthal.2023.07.002. Epub 2023 Jul 16.
LRG1 Promotes Diabetic Kidney Disease Progression by Enhancing TGF-β-Induced Angiogenesis.
Hong Q, Zhang L, Fu J, Verghese DA, Chauhan K, Nadkarni GN, Li Z, Ju W, Kretzler M, Cai GY, Chen XM, D'Agati VD, Coca SG, Schlondorff D, He JC, Lee K.
J Am Soc Nephrol. 2019 Apr;30(4):546-562. doi: 10.1681/ASN.2018060599. Epub 2019 Mar 11.
Common pathways in dementia and diabetic retinopathy: understanding the mechanisms of diabetes-related cognitive decline.
Little K, Llorián-Salvador M, Scullion S, Hernández C, Simó-Servat O, Del Marco A, Bosma E, Vargas-Soria M, Carranza-Naval MJ, Van Bergen T, Galbiati S, Viganò I, Musi CA, Schlingemann R, Feyen J, Borsello T, Zerbini G, Klaassen I, Garcia-Alloza M, Simó R, Stitt AW; RECOGNISED consortium (GA 847749).
Trends Endocrinol Metab. 2022 Jan;33(1):50-71. doi: 10.1016/j.tem.2021.10.008. Epub 2021 Nov 15.
Disruption of cortical cell type composition and function underlies diabetes-associated cognitive decline.
Little K, Singh A, Del Marco A, Llorián-Salvador M, Vargas-Soria M, Turch-Anguera M, Solé M, Bakker N, Scullion S, Comella JX, Klaassen I, Simó R, Garcia-Alloza M, Tiwari VK, Stitt AW; RECOGNISED consortium.
Diabetologia. 2023 Aug;66(8):1557-1575. doi: 10.1007/s00125-023-05935-2. Epub 2023 Jun 23.
Prevalence and risk factors of diabetic retinopathy in diabetic patients: A community based cross-sectional study.
Yin L, Zhang D, Ren Q, Su X, Sun Z.
Medicine (Baltimore). 2020 Feb;99(9):e19236. doi: 10.1097/MD.0000000000019236.
Diabetes-Related Macrovascular Complications Are Associated With an Increased Risk of Diabetic Microvascular Complications: A Prospective Study of 1518 Patients With Type 1 Diabetes and 20 802 Patients With Type 2 Diabetes in the UK Biobank.
Zhang X, Zhao S, Huang Y, Ma M, Li B, Li C, Zhu X, Xu X, Chen H, Zhang Y, Zhou C, Zheng Z.
J Am Heart Assoc. 2024 Jun 4;13(11):e032626. doi: 10.1161/JAHA.123.032626. Epub 2024 May 31.
Ocular Complications Associated With Diabetes And The Risk Of Sustainable Blindness; A Real World Analysis.
Mahmood T, Fahim MF, Ahsan S, Qidwai U, Memon MS.
J Pak Med Assoc. 2023 Jul;73(7):1453-1456. doi: 10.47391/JPMA.8001.
Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial.
Keech AC, Mitchell P, Summanen PA, O'Day J, Davis TM, Moffitt MS, Taskinen MR, Simes RJ, Tse D, Williamson E, Merrifield A, Laatikainen LT, d'Emden MC, Crimet DC, O'Connell RL, Colman PG; FIELD study investigators.
Lancet. 2007 Nov 17;370(9600):1687-97. doi: 10.1016/S0140-6736(07)61607-9. Epub 2007 Nov 7.
Plasma Metabolomics Identifies Key Metabolites and Improves Prediction of Diabetic Retinopathy: Development and Validation across Multinational Cohorts.
Yang S, Liu R, Xin Z, Zhu Z, Chu J, Zhong P, Zhu Z, Shang X, Huang W, Zhang L, He M, Wang W.
Ophthalmology. 2024 Dec;131(12):1436-1446. doi: 10.1016/j.ophtha.2024.07.004. Epub 2024 Jul 5.
Diabetes-Associated Hyperglycemia Causes Rapid-Onset Ocular Surface Damage.
Weng J, Ross C, Baker J, Alfuraih S, Shamloo K, Sharma A.
Invest Ophthalmol Vis Sci. 2023 Nov 1;64(14):11. doi: 10.1167/iovs.64.14.11.
